Found: 2
Select item for more details and to access through your institution.
First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 674, doi. 10.1007/s10637-018-0674-x
- By:
- Publication type:
- Article
Phase I study of lurbinectedin, a synthetic tetrahydroisoquinoline that inhibits activated transcription, induces DNA single- and double-strand breaks, on a weekly × 2 every-3-week schedule.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 4, p. 471, doi. 10.1007/s10637-017-0427-2
- By:
- Publication type:
- Article